Zobrazeno 1 - 4
of 4
pro vyhledávání: '"McCawley Clark‐Dickson"'
Autor:
David Stephen Prince, Glen Schlaphoff, Scott Anthony Davison, Ya Ruth Huo, Hao Xiang, Michael Vinchill Chan, Alice Unah Lee, Cynthuja Thailakanathan, Hazem Jebeili, Christopher Rogan, Ahmed Al‐Omary, Sidhartha Gupta, Ian Lockart, Neha Tiwari, McCawley Clark‐Dickson, James William Hillhouse, Robyn Laube, Jeff Chang, Vi Nguyen, Mark Danta, Robert Cheng, Simone Irene Strasser, Amany Zekry, Miriam Tania Levy, Christine Chan, Ken Liu
Publikováno v:
Journal of Gastroenterology and Hepatology. 37:2173-2181
The exact place for selective internal radiation therapy (SIRT) in the therapeutic algorithm for hepatocellular carcinoma (HCC) is debated. There are limited data on its indications, efficacy, and safety in Australia.We performed a multicenter retros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57ad553d1cdc798d8f2fddd81ea8cbb3
https://doi.org/10.1111/jgh.15986
https://doi.org/10.1111/jgh.15986
Publikováno v:
Endocrinology and Metabolism Clinics of North America.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ba147c1bfd7231960b4fcdb3e039322
https://doi.org/10.1016/j.ecl.2023.02.003
https://doi.org/10.1016/j.ecl.2023.02.003
Autor:
Kurvi Patwala, David Stephen Prince, Yael Celermajer, Waafiqa Alam, Eldho Paul, Simone Irene Strasser, Geoffrey William McCaughan, Paul Gow, Siddharth Sood, Elise Murphy, Stuart Roberts, Elliot Freeman, Elizabeth Stratton, Scott Anthony Davison, Miriam Tania Levy, McCawley Clark-Dickson, Vi Nguyen, Sally Bell, Amanda Nicoll, Ashley Bloom, Alice Unah Lee, Marno Ryan, Jessica Howell, Zina Valaydon, Alexandra Mack, Ken Liu, Anouk Dev
Introduction: Hepatocellular carcinoma (HCC) is a serious complication of chronic liver disease. Lenvatinib is an oral multikinase inhibitor registered to treat advanced HCC. This study evaluates the real-world experience with lenvatinib in Australia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8eddc759ea93d1633fa8a0411d33cea
https://doi.org/10.21203/rs.3.rs-1714922/v1
https://doi.org/10.21203/rs.3.rs-1714922/v1
Autor:
Kurvi Patwala, David Stephen Prince, Yael Celermajer, Waafiqa Alam, Eldho Paul, Simone Irene Strasser, Geoffrey William McCaughan, Paul Gow, Siddharth Sood, Elise Murphy, Stuart Roberts, Elliot Freeman, Elizabeth Stratton, Scott Anthony Davison, Miriam Tania Levy, McCawley Clark-Dickson, Vi Nguyen, Sally Bell, Amanda Nicoll, Ashley Bloom, Alice Unah Lee, Marno Ryan, Jessica Howell, Zina Valaydon, Alexandra Mack, Ken Liu, Anouk Dev
Publikováno v:
Hepatology international. 16(5)
Introduction Hepatocellular carcinoma (HCC) is a serious complication of chronic liver disease. Lenvatinib is an oral multikinase inhibitor registered to treat advanced HCC. This study evaluates the real-world experience with lenvatinib in Australia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8983130a8565d7af5f44946152453ce
https://pubmed.ncbi.nlm.nih.gov/36006547
https://pubmed.ncbi.nlm.nih.gov/36006547